Related Experiment Video

Updated: Jun 4, 2026

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Identification of blood microRNAs associated to Parkinsonĭs disease

Regina Margis1, Rogério Margis, Carlos R M Rieder

  • 1Neurology Section, Movement Disorders Unit, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, 90035-00 Porto Alegre, RS, Brazil.

Journal of Biotechnology
|February 8, 2011
PubMed

Insights

Blood samples reveal microRNA (miRNA) signatures for Parkinson's disease (PD). Six specific miRNAs can differentiate early-stage, untreated PD from healthy individuals and track treatment effectiveness in PD patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Parkinson's disease (PD) diagnosis relies on clinical symptoms, often appearing late.
  • Biomarkers for early and accurate PD detection are crucial for timely intervention.
  • MicroRNAs (miRNAs) are emerging as potential biomarkers due to their role in gene regulation.

Purpose of the Study:

  • To identify blood-based microRNA (miRNA) profiles associated with Parkinson's disease (PD).
  • To determine if specific miRNAs can differentiate between healthy controls, untreated PD patients, and treated PD patients.
  • To explore the potential of these miRNAs as diagnostic and prognostic biomarkers for PD.

Main Methods:

  • Blood samples were collected from control subjects and patients with Parkinson's disease (PD) at different stages and treatment statuses.
  • Quantitative real-time PCR (qRT-PCR) was employed to measure the expression levels of selected microRNAs (miRNAs).
  • Statistical analyses were performed to identify differentially expressed miRNAs and their correlation with PD status and treatment.

Main Results:

  • A distinct set of six differentially expressed microRNAs (miRNAs) was identified in blood samples of Parkinson's disease (PD) patients.
  • Three miRNAs (miR-1, miR-22*, miR-29) effectively distinguished untreated PD patients from healthy controls.
  • Three other miRNAs (miR-16-2*, miR-26a2*, miR30a) differentiated between treated and untreated PD patients.

Conclusions:

  • Blood-derived microRNAs (miRNAs) show significant potential as non-invasive biomarkers for Parkinson's disease (PD).
  • Specific miRNA signatures can aid in early diagnosis and monitoring of treatment response in PD.
  • This finding contributes to the development of novel diagnostic tools for Parkinson's disease.

More Related Videos

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons09:21

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons

Published on: July 7, 2023

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...